Canada markets closed
  • S&P/TSX

    20,230.96
    -0.36 (-0.00%)
     
  • S&P 500

    4,223.70
    -22.89 (-0.54%)
     
  • DOW

    34,033.67
    -265.66 (-0.77%)
     
  • CAD/USD

    0.8155
    -0.0053 (-0.65%)
     
  • CRUDE OIL

    71.86
    -0.26 (-0.36%)
     
  • BTC-CAD

    47,314.28
    -1,611.30 (-3.29%)
     
  • CMC Crypto 200

    959.54
    -32.93 (-3.32%)
     
  • GOLD FUTURES

    1,830.70
    -25.70 (-1.38%)
     
  • RUSSELL 2000

    2,316.57
    -3.50 (-0.15%)
     
  • 10-Yr Bond

    1.5690
    +0.0700 (+4.67%)
     
  • NASDAQ

    14,039.68
    -33.17 (-0.24%)
     
  • VOLATILITY

    17.62
    +0.60 (+3.53%)
     
  • FTSE

    7,184.95
    +12.47 (+0.17%)
     
  • NIKKEI 225

    29,291.01
    -150.29 (-0.51%)
     
  • CAD/EUR

    0.6788
    +0.0023 (+0.34%)
     

Abeona Therapeutics: Q4 Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

DALLAS (AP) _ Abeona Therapeutics Inc. (ABEO) on Wednesday reported a loss of $15.8 million in its fourth quarter.

On a per-share basis, the Dallas-based company said it had a loss of 17 cents.

The drug developer posted revenue of $3 million in the period.

For the year, the company reported that its loss widened to $84.2 million, or 91 cents per share. Revenue was reported as $10 million.

In the final minutes of trading on Wednesday, the company's shares hit $1.78. A year ago, they were trading at $2.07.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABEO at https://www.zacks.com/ap/ABEO